The North America continuous glucose monitoring devices market size was estimated at USD 5.36 billion in 2025 and is projected to be worth around USD 19.87 billion by 2035, expanding at a CAGR of 14% from 2026 to 2035. The Market is mainly fueled by the increasing rates of diabetes, the quick uptake of advanced, easy-to-use wearable sensors, and supportive reimbursement policies.

North America Continuous Glucose Monitoring Devices Market Statical Scope

The market is vital due to the high incidence of diabetes, which requires advanced tools for real-time management to enhance patient outcomes. It is expanding quickly, driven by the widespread use of digital health , favorable reimbursement policies, and technological advancements. The market is a leader globally in adopting innovative technologies like app-integrated devices and needle-free biosensors.

Innovations such as Dexcom G7 and Abbott FreeStyle Libre 3 provide real-time data, helping to lower the risk of hypoglycemia. The trend towards home diagnostics and personalized health management makes CGM devices crucial for effective, independent daily self-management.

North America Continuous Glucose Monitoring Devices Market, By Product, 2025 (%)

• Sensors - The sensor segment is the key part of the market because it represents a high-volume, ongoing cost, the demand for better accuracy, and its main role in delivering continuous, real-time data for modern, connected, and increasingly compact wearable diabetes management systems. This segment is the primary component for glucose measurement, holding a 45% market share due to its crucial function in continuous glucose monitoring systems.
• Device/Readers - The Device/Readers segment plays an important role in the market as it provides the necessary interface for showing, interpreting, and storing real-time glucose data from sensors. These devices, which include smartphone apps and dedicated handheld readers, enhance user convenience and improve diabetes management. This segment, which accounts for 30% of the market, is widely used for its role in real-time monitoring and user interaction.

North America Continuous Glucose Monitoring Devices Market, By Connectivity, 2025 (%)

• Bluetooth - The Bluetooth segment is essential in the market because it allows smooth, real-time data transfer from wearable sensors to smartphones, boosting user engagement, accuracy, and remote monitoring capabilities. This wireless technology for data transfer dominates with a 60% share and is preferred for its compatibility with smartphones and easy access to monitoring data.
• 4G/Cellular - The 4G/Cellular segment is vital in the market as it serves as a key enabler for remote, real-time data transmission to healthcare providers, leading to the fastest growth rate among connectivity types. This mobile network-based connectivity for continuous data transmission holds a 25% share and is increasingly adopted with the high use of mobile networks in medical devices .

North America Continuous Glucose Monitoring Devices Market, By Indication, 2025 (%)

• Type 1 Diabetes - The Type 1 Diabetes segment plays a vital role in the market, as it necessitates daily, intensive insulin management. High uptake of Dexcom G7 and Abbott Freestyle Libre 3 devices is used to avoid severe hyperglycemia or hypoglycemia. It is the leading indication for devices, holding a 40% market share, primarily used by individuals with Type 1 diabetes who need constant glucose monitoring.
• Type 2 Diabetes - The Type 2 diabetes segment is essential to the market, significantly contributing to volume due to its high prevalence and increasing insurance coverage eligibility. It is commanding a 60% share, as more individuals with Type 2 diabetes are turning to continuous glucose monitoring for better management.

North America Continuous Glucose Monitoring Devices Market, By Distribution Channel, 2025 (%)

• Pharmacies - The pharmacy segment is vital in the market, serving as the main, accessible, and trusted distribution channel. It is the leading distribution channel, with a 45% market share, due to the convenience and accessibility it provides for patients to acquire CGM devices.
• E-commerce - The e-commerce segment is important in the market, as it provides unmatched convenience, direct-to-consumer access, and competitive pricing. This increasingly popular distribution channel holds a 40% market share, fueled by online retail and consumer demand for more convenient purchasing options.

Recent Developments in the North America Continuous Glucose Monitoring Devices Market

• In Jun 2025, LifePlus, a startup from Silicon Valley, announced the clinical validation of LifeLeaf, the first non-invasive and cuffless wearable device for continuous tracking of glucose and blood pressure. This device, which has been tested in global multi-center trials, provides real-time insights without the need for needles, invasive sensors, or cuffs, establishing a new benchmark in scalable preventive care management.

Competitive Landscape

• Abbott Laboratories is recognized for its FreeStyle Libre range, which includes Libre 2 and Libre 3, providing 14-day wear and real-time alerts.
• Dexcom, Inc. is at the forefront with its Dexcom G6 and G7 systems, featuring 15-day sensors (G7) and AI-driven food logging.
• Medtronic plc offers the Guardian Connect system and combines sensors with insulin pumps like the MiniMed 780G for automated insulin adjustments.
• Senseonics Holdings Inc. stands out with Eversense, the first long-term, implantable CGM system that lasts up to 180 days.
• Ascensia Diabetes Care is known for its partnership in distributing Eversense and its CONTOUR NEXT brand devices.

Segments Covered in the Report

By Product

• Sensors
• Device/Readers
• Applicators
• Transmitters

By Connectivity

• Bluetooth
• 4G/Cellular
• Near Field Communication (NFC)

By Indication

• Type 1 Diabetes
• Type 2 Diabetes

By Distribution Channel

• Pharmacies
• E-commerce
• Other